Tema Oncology ETF (NASDAQ:CANC) Short Interest Up 13.8% in December

Tema Oncology ETF (NASDAQ:CANC) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 7,400 shares, an increase of 13.8% from the December 15th total of 6,500 shares. Based on an average daily trading volume, of 11,800 shares, the short-interest ratio is currently 0.6 days.

Tema Oncology ETF Trading Down 0.1 %

CANC opened at $24.46 on Monday. The stock’s fifty day simple moving average is $25.87 and its 200 day simple moving average is $27.65. Tema Oncology ETF has a 1-year low of $23.97 and a 1-year high of $30.11. The stock has a market cap of $57.48 million, a PE ratio of 26.86 and a beta of 1.11.

Tema Oncology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Thursday, December 12th. Stockholders of record on Wednesday, December 11th were given a $0.7283 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.

Institutional Trading of Tema Oncology ETF

An institutional investor recently bought a new position in Tema Oncology ETF stock. Thrivent Financial for Lutherans purchased a new stake in Tema Oncology ETF (NASDAQ:CANC) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 319,376 shares of the company’s stock, valued at approximately $8,616,000. Thrivent Financial for Lutherans owned 19.01% of Tema Oncology ETF as of its most recent SEC filing.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.